Six out of seven of our Dravet syndrome patients with SCN9A variants harbor either missense or splice site mutations in SCN1A while a sizable portion of published SCN1A mutations are predicted to lead to truncated proteins [8]. The gene discussed is SCN9A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.